Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs

First Department of Medicine, Osaka University School of Medicine, Japan.

OBJECTIVES: This study was undertaken to examine whether nitric oxide released in ischemic myocardium decreases the coronary vascular resistance and attenuates the severity of contractile and metabolic dysfunction. BACKGROUND: Endothelium-derived relaxing factor, recently identified as nitric oxide, is a potent relaxant of coronary smooth muscle. METHODS: The left anterior descending coronary artery was perfused through an extracorporeal bypass tube placed in the carotid artery in 56 open chest dogs. After hemodynamic stabilization, we occluded this bypass tube to decrease coronary blood flow to one third of the control flow. Thereafter, we maintained a constant coronary perfusion pressure (40.9 +/- 3.1 mm Hg). RESULTS: Under ischemic conditions, the coronary arteriovenous differences in nitrate and nitrite (end products of nitric oxide) increased (from 3.5 +/- 0.4 [mean +/- SEM] to 12.9 +/- 2.1 mumol/liter, p < 0.01). NG-Monomethyl L-arginine (3 micrograms/kg body weight per min, intracoronary) decreased the coronary arteriovenous differences in nitrate and nitrite (5.0 +/- 0.9 mumol/liter, p < 0.05) and coronary blood flow (from 29.8 +/- 0.5 to 18.1 +/- 1.1 ml/100 g per min, p < 0.001). Fractional shortening (from 3.7 +/- 1.0 to -1.3 +/- 0.7%, p < 0.001) and lactate extraction ratio (from -44.0 +/- 4.1 to -59.2 +/- 4.9%, p < 0.005) of the perfused area also decreased. These values were restored by the concomitant administration of L-arginine. Blood flow to the endomyocardium was decreased relative to the epimyocardium. A reduction in coronary blood flow and worsening of myocardial contractile and metabolic functions due to the administration of NG-monomethyl L-arginine during ischemia were observed in denervated hearts. A reduction in coronary blood flow in ischemic myocardium was observed with the administration of NW-nitro-L-arginine methyl ester as well, although neither NW-nitro-L-arginine methyl ester nor NG-monomethyl L-arginine changed coronary blood flow and myocardial contractile and metabolic functions in the nonischemic myocardium. The cyclic guanosine monophosphate content of epicardial coronary artery increased due to myocardial ischemia; this increase was attenuated with NG-monomethyl L-arginine treatment. CONCLUSIONS: We conclude that endogenous nitric oxide predominantly decreases the coronary vascular resistance of ischemic endomyocardium, thereby improving myocardial contractility and metabolic function.

This article has been cited by other articles:

				E. B. Manukhina, H. F. Downey, and R. T. Mallet Role of Nitric Oxide in Cardiovascular Adaptation to Intermittent Hypoxia Exp Biol Med, April 1, 2006; 231(4): 343 - 365. [Abstract] [Full Text] [PDF]

				N. P. Johnson and K. L. Gould Clinical Evaluation of a New Concept: Resting Myocardial Perfusion Heterogeneity Quantified by Markovian Analysis of PET Identifies Coronary Microvascular Dysfunction and Early Atherosclerosis in 1,034 Subjects J. Nucl. Med., September 1, 2005; 46(9): 1427 - 1437. [Abstract] [Full Text] [PDF]

				K. Takahashi, T. Komaru, S. Takeda, K. Sato, H. Kanatsuka, and K. Shirato Nitric oxide inhibition unmasks ischemic myocardium-derived vasoconstrictor signals activating endothelin type A receptor of coronary microvessels Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H85 - H91. [Abstract] [Full Text] [PDF]

				R. R. Martinez, S. Setty, P. Zong, J. D. Tune, and H. F. Downey Nitric oxide contributes to right coronary vasodilation during systemic hypoxia Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1139 - H1146. [Abstract] [Full Text] [PDF]

				M. Okamoto, K. Tsuchiya, Y. Kanematsu, Y. Izawa, M. Yoshizumi, S. Kagawa, and T. Tamaki Nitrite-derived nitric oxide formation following ischemia-reperfusion injury in kidney Am J Physiol Renal Physiol, January 1, 2005; 288(1): F182 - F187. [Abstract] [Full Text] [PDF]

				S. Setty, J. D. Tune, and H. F. Downey Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle Cardiovasc Res, December 1, 2004; 64(3): 431 - 436. [Abstract] [Full Text] [PDF]

				Y. Liao, M. Asakura, S. Takashima, A. Ogai, Y. Asano, Y. Shintani, T. Minamino, H. Asanuma, S. Sanada, J. Kim, et al. Celiprolol, A Vasodilatory {beta}-Blocker, Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Prevents the Transition to Heart Failure via Nitric Oxide-Dependent Mechanisms in Mice Circulation, August 10, 2004; 110(6): 692 - 699. [Abstract] [Full Text] [PDF]

				C. Martin, R. Schulz, H. Post, P. Gres, and G. Heusch Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2320 - H2324. [Abstract] [Full Text] [PDF]

				K. Sato, T. Komaru, H. Shioiri, S. Takeda, K. Takahashi, H. Kanatsuka, and K. Shirato Vasodilator signals from the ischemic myocardium are transduced to the coronary vascular wall by pertussis toxin-sensitive g proteins: A new experimental method for the analysis of the interaction between the myocardium and coronary vessels J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1859 - 1865. [Abstract] [Full Text] [PDF]

				G. Heusch, H. Post, M. C. Michel, M. Kelm, and R. Schulz Endogenous Nitric Oxide and Myocardial Adaptation to Ischemia Circ. Res., July 21, 2000; 87(2): 146 - 152. [Abstract] [Full Text] [PDF]

				M. Kitakaze, K. Node, T. Minamino, H. Asanuma, T. Kuzuya, and M. Hori A Ca channel blocker, benidipine, increases coronary blood flow and attenuates the severity of myocardial ischemia via NO-dependent mechanisms in dogs J. Am. Coll. Cardiol., January 1, 1999; 33(1): 242 - 249. [Abstract] [Full Text] [PDF]

				T. Minamino, M. Kitakaze, S. Sanada, H. Asanuama, T. Kurotobi, Y. Koretsune, M. Fukunami, T. Kuzuya, N. Hoki, and M. Hori Increased Expression of P-Selectin on Platelets Is a Risk Factor for Silent Cerebral Infarction in Patients With Atrial Fibrillation : Role of Nitric Oxide Circulation, October 27, 1998; 98(17): 1721 - 1727. [Abstract] [Full Text] [PDF]

				T. Minamino, M. Kitakaze, H. Sato, H. Asanuma, H. Funaya, Y. Koretsune, and M. Hori Plasma Levels of Nitrite/Nitrate and Platelet cGMP Levels Are Decreased in Patients With Atrial Fibrillation Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3191 - 3195. [Abstract] [Full Text]